Skip to content

Navigated OCT Imaging With the P200TxE

Navigated Peripheral OCT Imaging With the P200TxE

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04003831
Enrollment
26
Registered
2019-07-01
Start date
2019-06-13
Completion date
2021-01-18
Last updated
2021-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal Disease

Brief summary

The P200TxE will be used to obtain peripheral OCT (optical coherence tomography) images.

Interventions

DEVICEDevice: P200TxE

The P200TxE Ophthalmoscope provides widefield Scanning Laser Ophthalmoscope (SLO) fundus imaging and Optical Coherence Tomography (OCT) imaging in one device.

Sponsors

Optos, PLC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Male or female subjects 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed; 2. Subjects who can follow the instructions by the clinical staff at the clinical site, 3. Subjects who agree to participate in the study; 4. Subjects presenting with some form of peripheral retina pathology or retina pathology with peripheral manifestations.

Exclusion criteria

1. Subjects unable to tolerate ophthalmic imaging; 2. Subjects with ocular media not sufficiently clear to obtain acceptable OCT images;

Design outcomes

Primary

MeasureTime frameDescription
Qualitative Assessment of OCT Scan Quality1 yearImage quality of the OCT scans will be assessed from the clinician questionnaire using a four point scale.
Qualitative Assessment of OCT Clinical Utility1 yearClinical utility of the OCT scans will be assessed from the clinician questionnaire using a four point scale.

Secondary

MeasureTime frameDescription
Safety Assessment from Adverse Events1 yearAnalysis of safety will be assessed through adverse events reported by the site and documented on each subject's case report form.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026